Terns Pharmaceuticals Inc (TERN)
4.64 -0.03 (-0.64%) 01/23/25 [NASDAQ]
4.52 x 100 4.80 x 1,100
Realtime by (Cboe BZX)
4.52 x 100 4.80 x 1,100
Realtime 4.69 +0.05 (+1.08%) 18:06 ET
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 24,939 | 25,537 | 25,446 | 24,058 | 33,184 |
Operating Income | -24,939 | -25,537 | -25,446 | -24,058 | -33,184 |
Other Income | 3,056 | 2,862 | 3,170 | 3,088 | 3,475 |
Pre-tax Income | -21,883 | -22,675 | -22,276 | -20,970 | -29,709 |
Income Tax | 62 | 61 | 97 | 49 | 58 |
Net Income Continuous | -21,945 | -22,736 | -22,373 | -21,019 | -29,767 |
Net Income | $-21,945 | $-22,736 | $-22,373 | $-21,019 | $-29,767 |
EPS Basic Total Ops | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 |
EPS Basic Continuous Ops | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 |
EPS Diluted Total Ops | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 |
EPS Diluted Continuous Ops | -0.28 | -0.31 | -0.30 | -0.29 | -0.42 |
EPS Diluted Before Non-Recurring Items | N/A | -0.31 | -0.30 | -0.29 | -0.42 |
EBITDA(a) | $-24,733 | $-24,937 | $-25,570 | $-28,867 | $-32,962 |